We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.
Agenda
Agenda subject to change.
Additional faculty to be confirmed.
Friday, April 24
Times provided are in Pacific Standard Time.
Time
Topic
6:00 PM - 7:00 PM
Welcome Reception
Saturday, April 25
Time
Topic
Speaker
7:30 AM - 8:30 AM
Breakfast
8:30 AM
Welcome, Introductions, and Presession Survey
Ajai Chari, MD
8:40 AM
My Evolving Management of Patients With Smoldering MM
Peter Voorhees, MD
9:05 AM
Q&A Session
Moderated by: Ajai Chari, MD
9:15 AM
My Evolving Management of Transplant-Eligible
and -Ineligible Patients With NDMM
Ajay Nooka, MD, MPH, FACP
9:40 AM
Q&A Session
Moderated by: Ajai Chari, MD
9:50 AM
Case-Based Panel: Management of Patients With SMM and NDMM
Amrita Krishnan, MD
Ajay Nooka, MD, MPH, FACP
Peter Voorhees, MD
10:10 AM
Morning Break
10:25 AM
CAR T-Cell Therapy: Current and Future Timing and Novel Products
Krina Patel, MD
10:45 AM
Bispecific Antibodies and T-Cell Engagers: Current and Future Timing and Novel Products
Jesus Berdeja, MD
11:05 AM
Non-T-Cell Redirection Therapies: Current and Future Timing and Novel Products
Dan Vogl, MD, MCSE
11:25 AM
Q&A Session
Moderated by: Ajai Chari, MD
11:35 AM
Case-Based Panel: Management of Patients With RRMM
Jesus Berdeja, MD
Jodi Lipof, MD
Krina Patel, MD
12:05 PM
Lunch
1:00 PM
Keynote: Administration of Bispecific Antibodies for Patients With Multiple Myeloma
Jeffrey Matous, MD
1:25 PM
Keynote: Administration of Bispecific Antibodies for Patients With Other Hematologic Malignancies
Madhav Seshadri, MD
1:50 PM
Q&A Session
Moderated by: Ajai Chari, MD
2:00 PM
Case-Based Panel: Management of Patients Receiving Bispecific Antibody Therapy
Jesus Berdeja, MD
Alfred Chung, MD
Jeffrey Matous, MD
Jorge Monge, MD
Darren Pan, MD
2:25 PM
Postsession Survey
Ajai Chari, MD
2:30 PM
Program Adjourns